The International Liaison Committee on Resuscitation conducts continuous review of new peer-reviewed published cardiopulmonary resuscitation science and publishes annual summaries. More comprehensive ...

Learn about nebulized therapy and other inhaled medication delivery devices for asthma and COPD. Access the healthcare provider tools and patient education from the Lung Association and our partners.

Lavender has long been associated with calm, cleanliness, and comfort, but its reputation is not built on fragrance alone.

Background: Oxidative stress is a common pathological condition in postmenopausal osteoporosis. Glutathione reductase, an antioxidant enzyme, plays a critical role in the body’s antioxidant defense ...

Please provide your email address to receive an email when new articles are posted on . Depemokimab is a twice-yearly treatment. The FDA based depemokimab’s approval on phase 3 SWIFT-1 and SWIFT-2 ...

Treatment with twice-yearly depemokimab resulted in a significant reduction in the rate of annualized asthma exacerbations compared with placebo. The Food and Drug Administration (FDA) has approved ...

1 Department of Molecular Physiology, Institute of Integrative Cell Biology and Physiology, University of Münster, Münster, Germany 2 Department of Ophthalmology, Charité, Berlin, Germany Figure 1.

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. Tuesday, the U.S. regulator greenlit GSK’s depemokimab, an ultra-long-acting ...